SCHEMBL21888074

SCHEMBL21888074

NC(=O)c1ncn([C@@H]2O[C@H](CCP(=O)(O)O)CC2=O)n1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
ADORA1 P30542 2/20 0.41
ALDH1A1 P00352 1/20 0.41
GLA P06280 1/20 0.41
EIF4E P06730 1/20 0.41
CYP3A4 P08684 1/20 0.41
TOP1 P11387 1/20 0.41
TSHR P16473 1/20 0.41
THPO P40225 1/20 0.41
PMP22 Q01453 1/20 0.41
HTR2C P28335 1/20 0.38
HTR2B P41595 1/20 0.38
SLC6A3 Q01959 1/20 0.38
TMEM97 Q5BJF2 1/20 0.38
ENPP1 P22413 5/20 0.33
ENPP3 O14638 1/20 0.32
P2RY2 P41231 1/20 0.30
PNP P00491 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21888907 0.83 LMNA (0.40) LMNASMN1; SMN2ADORA1ALDH1A1GLA
SCHEMBL21888945 0.80 LMNA (0.43) LMNASMN1; SMN2ADORA1ALDH1A1GLA
SCHEMBL21888137 0.73 LMNA (0.49) LMNASMN1; SMN2ADORA1ALDH1A1GLA
SCHEMBL21887943 0.73 LMNA (0.46) LMNASMN1; SMN2ADORA1ALDH1A1GLA
SCHEMBL24024426 0.73 LMNA (0.70) LMNASMN1; SMN2ADORA1ALDH1A1GLA
SCHEMBL24024696 0.73 LMNA (0.70) LMNASMN1; SMN2ADORA1ALDH1A1GLA
SCHEMBL21888051 0.69 LMNA (0.41) LMNASMN1; SMN2ADORA1ALDH1A1GLA
SCHEMBL21888048 0.69 LMNA (0.41) LMNASMN1; SMN2ADORA1ALDH1A1GLA
SCHEMBL21887950 0.68 LMNA (0.41) LMNASMN1; SMN2ADORA1ALDH1A1GLA
SCHEMBL21888937 0.68 ATG7 (0.36) LMNASMN1; SMN2ADORA1ALDH1A1GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020072931-A2 PRE-ACTIVATED NUCLEOSIDE IMPDH INHIBITORS AS ANTI-INFECTIVE DRUGS OCTAGON THERAPEUTICS INC. (US) 2020-04-09 WO disclosed